USD 0.01
(-14.81%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 49.94 Thousand USD | 0.11% |
2022 | 49.88 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 911.20 USD | 0.0% |
2018 | 911.20 USD | 0.0% |
2016 | 911 Thousand USD | -13.42% |
2015 | 1.05 Million USD | 29.81% |
2014 | 810.55 Thousand USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | -100.0% |
2005 | 274.00 USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 FY | 49.94 Thousand USD | 0.11% |
2023 Q3 | 48.86 Thousand USD | -2.01% |
2023 Q4 | 49.94 Thousand USD | 2.21% |
2023 Q1 | 48.86 Thousand USD | -2.04% |
2023 Q2 | 49.86 Thousand USD | 2.03% |
2022 Q2 | 61.47 Thousand USD | 6147200.0% |
2022 Q4 | 49.88 Thousand USD | 0.96% |
2022 FY | 49.88 Thousand USD | 0.0% |
2022 Q1 | 1.00 USD | 0.0% |
2022 Q3 | 49.41 Thousand USD | -19.62% |
2021 Q1 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 FY | - USD | -100.0% |
2019 FY | 911.20 USD | 0.0% |
2018 FY | 911.20 USD | 0.0% |
2016 FY | 911 Thousand USD | -13.42% |
2015 FY | 1.05 Million USD | 29.81% |
2014 FY | 810.55 Thousand USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 FY | - USD | -100.0% |
2006 Q1 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2005 FY | 274.00 USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
American Medical Technologies Inc. | 133.82 Thousand USD | 62.684% |
Ansell Limited | 457.04 Million USD | 99.989% |
Ansell Limited | 457.9 Million USD | 99.989% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 43.33 Million USD | 99.885% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 27.89 Thousand USD | -79.061% |
ConvaTec Group Plc | 395.54 Million USD | 99.987% |
ConvaTec Group Plc | 396.1 Million USD | 99.987% |
Encision Inc. | 1.4 Million USD | 96.439% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | -9294.00 USD | 637.336% |
LifePoint, Inc. | 2.3 Million USD | 97.837% |
Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 97.922% |
Paradigm Medical Industries, Inc. | 441 Thousand USD | 88.676% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 91.88 Thousand USD | 45.648% |
Reflect Scientific, Inc. | 972.29 Thousand USD | 94.864% |
SmileDirectClub, Inc. | 49.87 Million USD | 99.9% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 99.986% |
SheerVision, Inc. | 339.66 Thousand USD | 85.297% |
United Health Products, Inc. | 33.59 Thousand USD | -48.64% |
Vasamed, Inc. | 449.02 Thousand USD | 88.878% |
Wearable Health Solutions, Inc. | 8555.00 USD | -483.752% |
Yubo International Biotech Limited | 322.17 Thousand USD | 84.499% |